Health Sciences Acquisitions Co. 2 (HSAQ) Stock Chart & Stock Price History → READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad) Free HSAQ Stock Alerts $4.95 +0.07 (+1.43%) (As of 05/9/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsSocial Media Health Sciences Acquisitions Co. 2 Stock Price Performance5 Day Performance-2.94%1 Month Performance+1.23%3 Month Performance-30.58%6 Month Performance-4.81%Year-To-Date Performance-45.78%1 Year Performance-72.35% Receive HSAQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Health Sciences Acquisitions Co. 2 and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. HSAQ Stock Chart for Friday, May, 10, 2024 HSAQ Chart by TradingView Health Sciences Acquisitions Co. 2 Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/09/2024$4.98$4.95-0.60%$4.99$4.8218,308 shs$55.50 million05/08/2024$5.24$4.98-4.96%$5.14$4.9529,395 shs$55.84 million05/07/2024$5.24$5.24$5.35$4.8133,605 shs$58.75 million05/06/2024$5.10$5.24+2.75%$5.35$4.8133,575 shs$58.75 million05/03/2024$5.55$5.10-8.11%$5.42$4.9568,178 shs$57.18 million05/02/2024$4.40$5.55+26.14%$5.56$4.2938,978 shs$62.23 million Get the Latest News and Ratings for HSAQ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Health Sciences Acquisitions Co. 2 and its competitors with MarketBeat's FREE daily newsletter. 05/01/2024$4.41$4.40-0.23%$4.49$4.2944,539 shs$49.33 million04/30/2024$4.39$4.41+0.46%$4.43$4.3255,953 shs$49.45 million04/29/2024$4.39$4.39$4.60$4.3624,286 shs$49.22 million04/26/2024$4.44$4.39-1.13%$4.60$4.3624,286 shs$49.22 million04/25/2024$4.48$4.44-0.89%$4.57$4.2255,556 shs$49.78 million04/24/2024$4.52$4.48-0.88%$4.63$4.4424,426 shs$50.23 million04/23/2024$4.64$4.52-2.59%$4.52$4.4529,371 shs$50.68 million04/22/2024$4.64$4.64$4.79$4.5222,488 shs$52.02 million04/19/2024$4.71$4.71$4.78$4.5230,357 shs$52.81 million04/18/2024$4.62$4.71+1.95%$4.78$4.5230,144 shs$52.81 million04/17/2024$4.66$4.62-0.86%$4.94$4.5516,272 shs$51.80 million04/16/2024$4.89$4.66-4.70%$4.89$4.6531,368 shs$52.25 million04/15/2024$4.89$4.89$5.03$4.8313,432 shs$54.83 million04/12/2024$5.05$4.89-3.17%$5.03$4.8313,431 shs$54.83 million04/11/2024$4.89$5.05+3.27%$5.05$4.7033,499 shs$56.62 million04/10/2024$4.89$4.89$4.99$4.8020,828 shs$54.83 million04/09/2024$4.93$4.89-0.81%$5.13$4.8023,215 shs$54.83 million04/08/2024$4.89$4.93+0.82%$5.05$4.8025,681 shs$55.28 million04/05/2024$4.97$4.89-1.61%$4.95$4.8141,489 shs$54.83 million04/04/2024$4.90$4.97+1.43%$5.14$4.9133,383 shs$55.72 million04/03/2024$5.04$4.90-2.78%$5.17$4.8658,009 shs$54.94 million04/02/2024$4.95$5.04+1.82%$5.06$4.6537,949 shs$56.51 million04/01/2024$5.27$4.95-6.07%$5.59$4.7757,662 shs$55.50 million03/29/2024$5.27$5.27$5.62$5.18100,172 shs$59.09 million03/28/2024$5.31$5.27-0.66%$5.62$5.18100,171 shs$59.09 million03/27/2024$5.00$5.31+6.10%$5.70$5.0046,225 shs$59.48 million03/26/2024$5.00$5.00$5.26$5.0033,476 shs$56.06 million03/25/2024$5.26$5.00-4.94%$5.26$5.0033,476 shs$56.06 million03/22/2024$5.31$5.26-0.94%$5.36$5.0540,544 shs$58.98 million03/21/2024$5.35$5.31-0.65%$5.73$5.2561,180 shs$59.54 million03/20/2024$5.30$5.35+0.85%$5.53$5.3062,249 shs$59.93 million03/19/2024$5.36$5.30-1.12%$5.54$5.3051,015 shs$59.42 million03/18/2024$5.16$5.36+3.88%$5.41$5.1564,526 shs$60.10 million03/15/2024$5.32$5.32$5.50$5.3028,361 shs$59.65 millionProof that the Musk/Bezos rivalry is about to hit a new level (Ad)Elon Musk Humiliated Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats…Go here now for full story.03/14/2024$5.46$5.32-2.56%$5.50$5.3027,033 shs$59.65 million03/13/2024$5.44$5.46+0.37%$5.87$5.3876,041 shs$61.22 million03/12/2024$5.71$5.44-4.73%$5.85$5.3374,993 shs$60.99 million03/11/2024$6.25$5.71-8.64%$6.64$5.7144,585 shs$64.02 million03/08/2024$6.95$6.49-6.62%$7.10$6.4137,381 shs$72.77 million03/07/2024$7.12$6.95-2.39%$7.15$6.6734,134 shs$77.92 million03/06/2024$7.12$7.12$7.23$6.9221,122 shs$79.83 million03/05/2024$6.86$7.12+3.79%$7.23$6.9221,122 shs$79.83 million03/04/2024$6.86$6.86$6.92$6.4225,643 shs$76.91 million03/01/2024$6.34$6.44+1.58%$6.67$6.20106,412 shs$72.21 million02/29/2024$6.34$6.34$6.50$6.2613,396 shs$71.08 million02/28/2024$6.34$6.34$6.42$6.1113,535 shs$71.08 million02/27/2024$6.04$6.34+4.97%$6.42$6.1113,534 shs$71.08 million02/26/2024$6.04$6.04$6.14$5.6533,646 shs$67.72 million02/23/2024$5.69$5.69$5.94$5.6332,440 shs$63.80 million02/22/2024$5.90$5.69-3.56%$5.94$5.6332,430 shs$63.80 million02/21/2024$6.39$5.90-7.67%$6.35$5.9081,579 shs$66.15 million02/20/2024$6.39$6.39$6.91$6.3928,122 shs$71.65 million02/19/2024$6.39$6.39$6.91$6.3928,122 shs$71.65 million02/16/2024$6.98$6.98$6.98$6.1845,867 shs$78.26 million02/15/2024$6.28$6.98+11.15%$6.98$6.1845,867 shs$78.26 million02/14/2024$7.17$6.28-12.41%$6.68$6.2834,982 shs$70.41 million02/13/2024$7.13$7.17+0.56%$7.45$6.9651,679 shs$80.39 million02/12/2024$7.13$7.13$7.27$6.8029,711 shs$79.94 million02/09/2024$6.79$6.95+2.36%$7.09$6.73107,004 shs$77.92 million Related Companies: Pro-Dex Stock Chart Sensus Healthcare Stock Chart Monogram Orthopaedics Stock Chart IceCure Medical Stock Chart Autonomix Medical Stock Chart SEP Acquisition Stock Chart Lucid Diagnostics Stock Chart Cytosorbents Stock Chart enVVeno Medical Stock Chart InspireMD Stock Chart Receive HSAQ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Health Sciences Acquisitions Co. 2 and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:HSAQ) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingShocking: One AI startup's revenue could surge 4,735%Manward PressHe Is Giving Away BitcoinCrypto Swap ProfitsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsCharles Payne Demystifies OptionsUnstoppable Prosperity[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsBiden Nomination CANCELED?The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Sciences Acquisitions Co. 2 Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.